Esperion Therapeutics
ESPR
#7628
Rank
โ‚น25.78 B
Marketcap
โ‚น130.34
Share price
0.00%
Change (1 day)
-28.15%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -โ‚น2.41 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚น0.29 Billion. In 2023 the company made an earning of -โ‚น13.06 Billion, an increase over its 2022 earnings that were of -โ‚น15.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น2.41 Billion-81.57%
2023 -โ‚น13.06 Billion-15.03%
2022 -โ‚น15.37 Billion-20.61%
2021 -โ‚น19.36 Billion84.28%
2020 -โ‚น10.51 Billion35.75%
2019 -โ‚น7.74 Billion-55.71%
2018 -โ‚น17.48 Billion19.57%
2017 -โ‚น14.62 Billion125.39%
2016 -โ‚น6.49 Billion51.43%
2015 -โ‚น4.29 Billion36.45%
2014 -โ‚น3.14 Billion43.55%
2013 -โ‚น2.19 Billion145.26%
2012 -โ‚น0.9 Billion
2002 -โ‚น2.55 Billion-7.81%
2001 -โ‚น2.76 Billion15.03%
2000 -โ‚น2.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น43.85 Billion 1,646.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น34.01 B-1,455.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น603.29 B-24,136.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น415.33 B-16,648.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น2.5 Billion-0.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น18.81 Billion 649.15%๐Ÿ‡บ๐Ÿ‡ธ USA